Combined Immunodeficiencies IEIs (IUIS Table 1)

IUIS Table 1 — immunodeficiencies affecting both cellular and humoral immunity. These combined immunodeficiencies (CID) and severe combined immunodeficiencies (SCID) feature impaired T-cell development or function with secondary B-cell/antibody defects, predisposing to early-onset opportunistic and bacterial infections.

Why this grouping

Grouped on the IUIS Table 1 combined cellular-and-humoral immunodeficiency phenotype. Members differ in the causal gene and whether T-cell deficiency is severe (SCID-equivalent) or moderate (CID). Kept as separate Disease entries because gene, inheritance, and syndromic features differ. Syndromic forms with prominent non-immune features are grouped under the sibling Combined Immunodeficiency with Syndromic Features IEIs grouping.

MONDO alignment & provenance

skos:broadMatch MONDO:0015131 · combined immunodeficiency

IUIS Table 1 aligns closely with MONDO combined immunodeficiency (MONDO:0015131), but MONDO does not nest that class under inborn error of immunity (MONDO:0003778) — both are immune-system-disorder siblings. broadMatch because this is an IUIS-guided partial union: Activated PI3K-delta syndrome is classified under IUIS combined immunodeficiency but sits outside MONDO:0015131's is-a subtree. See `grouping_mondo_gaps.py --audit`.

MONDO consistency: consistent 2/3 listed members are is-a descendants of MONDO:0015131. Activated PI3K-delta syndrome is an IUIS Table 1 member, but MONDO:0018338 lies outside this subtree; this discrepancy is recorded rather than used to determine IUIS-table membership.

Membership criteria

NECESSARY  (member ⇒ criteria)
A disorder belongs to IUIS Table 1 if it is an IEI with combined cellular and humoral immunodeficiency without syndromic features being the primary organizing axis.
  • HAS CLASSIFICATION
    Assigned to IUIS Table 1 (combined immunodeficiency) on the member Disease entry via classifications.iuis_category. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block rather than a free-text `parents:`/`categories:` tag that happens to use the same words.

Coverage and gaps

5 rows Exact MONDO scope not assessed 5 listed with MONDO ID

No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.

Status DisMech entry MONDO concept In DisMech Has MONDO ID In grouping MONDO Member state Conditions satisfied C1.1 Assigned to IUIS Table 1 (combined immunodeficiency) on the member Disease entry via classifications.iuis_category. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block rather than a free-text `parents:`/`categories:` tag that happens to use the same words.
listed with MONDO ID
Activated PI3K-delta syndrome DISEASE
Differentiating mechanism
Heterozygous gain-of-function PIK3CD or PIK3R1 variants hyperactivate PI3K-delta-AKT-mTOR signaling, causing lymphoproliferation, bronchiectasis, and herpesvirus susceptibility with immune dysregulation (APDS). PIK3CD hgnc:8977
Activated PI3K-delta syndrome
MONDO:0018338
yes yes not assessed listed satisfied SATISFIED
listed with MONDO ID
Cernunnos-XLF deficiency DISEASE
Differentiating mechanism
Biallelic NHEJ1 (Cernunnos/XLF) deficiency impairs nonhomologous end-joining, causing microcephaly, growth retardation, and combined T-/B-cell immunodeficiency with radiosensitivity. NHEJ1 hgnc:25737
Cernunnos-XLF deficiency
MONDO:0012650
yes yes not assessed listed satisfied SATISFIED
listed with MONDO ID
STK4 Deficiency DISEASE
Differentiating mechanism
Biallelic STK4 (MST1) loss impairs naive T-cell survival via FOXO1 and IL-7R/BCL2, with defective lymphocyte adhesion and chemotaxis; combined T- and B-cell lymphopenia with autoimmunity and EBV-driven lymphoproliferation. STK4 hgnc:11408
STK4 deficiency
MONDO:0013934
yes yes not assessed listed satisfied SATISFIED
listed with MONDO ID
Immunodeficiency 131 DISEASE
Differentiating mechanism
A recurrent heterozygous IRF4 p.Thr95Arg substitution in the DNA-binding domain acts simultaneously as hypomorph, hypermorph and neomorph (multimorphic), altering IRF4's DNA-binding specificity rather than merely reducing its output. The result is agammaglobulinemia with impaired B-cell maturation and class switching plus reduced TH17/TFH populations, and susceptibility to Pneumocystis jirovecii pneumonia — an autosomal dominant combined immunodeficiency, and one of the seven Table 1 entities newly recognized in the IUIS 2024 update. IRF4 hgnc:6119
immunodeficiency 131
MONDO:0976229
yes yes not assessed listed satisfied SATISFIED
listed with MONDO ID
Severe Combined Immunodeficiency DISEASE
Differentiating mechanism
The severe end of IUIS Table 1: profound failure of T-lymphocyte development that abrogates adaptive immunity from birth, reached by three mechanistically distinct routes — defective common-gamma-chain cytokine receptor signaling (IL2RG, JAK3, IL7R), failed V(D)J recombination or DNA double-strand-break repair (RAG1, RAG2, DCLRE1C/Artemis), and purine-salvage metabolite toxicity (ADA). Unlike the gene-specific Table 1 members alongside it, this entry is curated as the SCID concept itself, with the causal genes carried as subtypes. IL2RG hgnc:6010
severe combined immunodeficiency
MONDO:0015974
yes yes not assessed listed satisfied SATISFIED

Source

View YAML on GitHub
Raw YAML
name: Combined Immunodeficiencies IEIs
display_name: Combined Immunodeficiencies IEIs (IUIS Table 1)
creation_date: "2026-06-13T00:00:00Z"
description: >-
  IUIS Table 1 — immunodeficiencies affecting both cellular and humoral
  immunity. These combined immunodeficiencies (CID) and severe combined
  immunodeficiencies (SCID) feature impaired T-cell development or function
  with secondary B-cell/antibody defects, predisposing to early-onset
  opportunistic and bacterial infections.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
  Grouped on the IUIS Table 1 combined cellular-and-humoral immunodeficiency
  phenotype. Members differ in the causal gene and whether T-cell deficiency
  is severe (SCID-equivalent) or moderate (CID). Kept as separate Disease
  entries because gene, inheritance, and syndromic features differ. Syndromic
  forms with prominent non-immune features are grouped under the sibling
  Combined Immunodeficiency with Syndromic Features IEIs grouping.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0015131
      label: combined immunodeficiency
    mapping_predicate: skos:broadMatch
    mapping_source: MONDO
    mapping_justification: >-
      IUIS Table 1 aligns closely with MONDO combined immunodeficiency
      (MONDO:0015131), but MONDO does not nest that class under inborn error
      of immunity (MONDO:0003778) — both are immune-system-disorder siblings.
      broadMatch because this is an IUIS-guided partial union: Activated
      PI3K-delta syndrome is classified under IUIS combined immunodeficiency
      but sits outside MONDO:0015131's is-a subtree. See
      `grouping_mondo_gaps.py --audit`.
    consistency:
    - reference: MONDO
      consistent: CONSISTENT
      notes: >-
        2/3 listed members are is-a descendants of MONDO:0015131. Activated
        PI3K-delta syndrome is an IUIS Table 1 member, but MONDO:0018338
        lies outside this subtree; this discrepancy is recorded rather than
        used to determine IUIS-table membership.
membership_criteria:
- description: >-
    A disorder belongs to IUIS Table 1 if it is an IEI with combined cellular
    and humoral immunodeficiency without syndromic features being the primary
    organizing axis.
  criteria_semantics: NECESSARY
  logic:
    criterion_predicate: HAS_CLASSIFICATION
    classification: "iuis_category:combined immunodeficiency"
    description: >-
      Assigned to IUIS Table 1 (combined immunodeficiency) on the member
      Disease entry via classifications.iuis_category. Stated in the keyed
      `<slot>:<value>` form so the audit reads the structured
      classifications block rather than a free-text `parents:`/`categories:`
      tag that happens to use the same words.
members:
- member: STK4 Deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Biallelic STK4 (MST1) loss impairs naive T-cell survival via FOXO1 and
      IL-7R/BCL2, with defective lymphocyte adhesion and chemotaxis; combined
      T- and B-cell lymphopenia with autoimmunity and EBV-driven
      lymphoproliferation.
    gene:
      preferred_term: STK4
      term:
        id: hgnc:11408
        label: STK4
- member: Cernunnos-XLF deficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Biallelic NHEJ1 (Cernunnos/XLF) deficiency impairs nonhomologous
      end-joining, causing microcephaly, growth retardation, and combined
      T-/B-cell immunodeficiency with radiosensitivity.
    gene:
      preferred_term: NHEJ1
      term:
        id: hgnc:25737
        label: NHEJ1
- member: Activated PI3K-delta syndrome
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      Heterozygous gain-of-function PIK3CD or PIK3R1 variants hyperactivate
      PI3K-delta-AKT-mTOR signaling, causing lymphoproliferation,
      bronchiectasis, and herpesvirus susceptibility with immune dysregulation
      (APDS).
    gene:
      preferred_term: PIK3CD
      term:
        id: hgnc:8977
        label: PIK3CD
- member: Severe Combined Immunodeficiency
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      The severe end of IUIS Table 1: profound failure of T-lymphocyte
      development that abrogates adaptive immunity from birth, reached by
      three mechanistically distinct routes — defective common-gamma-chain
      cytokine receptor signaling (IL2RG, JAK3, IL7R), failed V(D)J
      recombination or DNA double-strand-break repair (RAG1, RAG2,
      DCLRE1C/Artemis), and purine-salvage metabolite toxicity (ADA). Unlike
      the gene-specific Table 1 members alongside it, this entry is curated as
      the SCID concept itself, with the causal genes carried as subtypes.
    gene:
      preferred_term: IL2RG
      term:
        id: hgnc:6010
        label: IL2RG
- member: Immunodeficiency 131
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      A recurrent heterozygous IRF4 p.Thr95Arg substitution in the DNA-binding
      domain acts simultaneously as hypomorph, hypermorph and neomorph
      (multimorphic), altering IRF4's DNA-binding specificity rather than
      merely reducing its output. The result is agammaglobulinemia with
      impaired B-cell maturation and class switching plus reduced TH17/TFH
      populations, and susceptibility to Pneumocystis jirovecii pneumonia —
      an autosomal dominant combined immunodeficiency, and one of the seven
      Table 1 entities newly recognized in the IUIS 2024 update.
    gene:
      preferred_term: IRF4
      term:
        id: hgnc:6119
        label: IRF4
notes: >-
  Expanded 2026-08-20 with Severe Combined Immunodeficiency and Immunodeficiency
  131 (IRF4), both of which already carried
  `classifications.iuis_category: combined immunodeficiency` but were not listed
  here. Note the two member shapes now sitting side by side: three gene-specific
  entities (STK4, NHEJ1, PIK3CD/PIK3R1) and one concept-level entity (SCID)
  whose causal genes are carried as `has_subtypes` rather than as separate
  Disease entries. IUIS Table 1 enumerates 73 mutant genes, so neither shape is
  wrong, but a consumer counting members of this grouping is not counting IUIS
  entities.